1. Home
  2. FLUX vs NRSN Comparison

FLUX vs NRSN Comparison

Compare FLUX & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLUX

Flux Power Holdings Inc.

HOLD

Current Price

$0.63

Market Cap

14.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.43

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLUX
NRSN
Founded
N/A
2017
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.1M
14.2M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
FLUX
NRSN
Price
$0.63
$0.43
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
431.0K
257.9K
Earning Date
05-07-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
5.00
N/A
EPS
N/A
N/A
Revenue
$9,317,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$23.01
$583.67
P/E Ratio
N/A
N/A
Revenue Growth
126.25
N/A
52 Week Low
$0.47
$0.25
52 Week High
$7.55
$1.30

Technical Indicators

Market Signals
Indicator
FLUX
NRSN
Relative Strength Index (RSI) 48.25 42.78
Support Level $0.51 $0.39
Resistance Level $0.85 $0.74
Average True Range (ATR) 0.09 0.06
MACD 0.01 0.01
Stochastic Oscillator 33.28 72.28

Price Performance

Historical Comparison
FLUX
NRSN

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc. designs, develops, manufactures, and sells a portfolio of lithium-ion energy storage solutions for the electrification of a range of industrial and commercial sectors, which include material handling, airport ground support equipment (GSE), and stationary energy storage. It offers a high-power battery cell management system(BMS). The BMS serves as the brain of the energy storage solution, managing cell balancing, charging, discharging, monitoring, and communication between the pack and the forklift. The company's product portfolio includes Battery Technology and Energy Management solutions.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: